EXAGEN INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
EXAGEN INC. (XGN) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-04
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $167.00K.
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.56M.
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $681.00K, a 32.37% decline year-over-year.
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.18M, a 96.99% increase year-over-year.
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $251.00K.
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$133.00K, a 105.33% decline from fiscal 2023.
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.50M.
- EXAGEN INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$1.40M, a 242.48% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.39M 10-Q · filed 2026-08-04 | -$709.00K derived: sum of 3 quarters · filed 2026-08-04 | $471.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | -$1.56M 10-Q · filed 2026-05-11 | -$876.00K derived: sum of 2 quarters · filed 2026-05-11 | $304.00K derived: sum of 3 quarters · filed 2026-05-11 | $112.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.86M derived: sum of 2 quarters · filed 2026-03-10 | $1.67M derived: sum of 3 quarters · filed 2026-08-04 | $251.00K 10-K · filed 2026-03-10 | ||
| 2025-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $988.00K derived: sum of 2 quarters · filed 2026-08-04 | -$430.00K 10-Q · filed 2025-11-04 | $577.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | -$192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.61M 10-Q · filed 2026-08-04 | -$603.00K derived: sum of 3 quarters · filed 2026-08-04 | -$4.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | -$1.42M 10-Q · filed 2026-05-11 | -$411.00K derived: sum of 2 quarters · filed 2026-05-11 | $188.00K derived: sum of 3 quarters · filed 2026-05-11 | -$120.00K derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.61M derived: sum of 2 quarters · filed 2026-03-10 | $1.30M derived: sum of 3 quarters · filed 2026-03-10 | -$133.00K 10-K · filed 2026-03-10 | $600.00K 10-K · filed 2025-03-11 | |
| 2024-09-30 | $599.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $291.00K derived: sum of 2 quarters · filed 2025-11-04 | -$1.14M 10-Q · filed 2025-11-04 | -$643.00K derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | -$308.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$1.74M 10-Q · filed 2025-07-29 | -$1.24M derived: sum of 3 quarters · filed 2025-07-29 | -$54.00K derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2024-03-31 | -$1.43M 10-Q · filed 2025-05-05 | -$934.00K derived: sum of 2 quarters · filed 2025-05-05 | $254.00K derived: sum of 3 quarters · filed 2025-05-05 | $173.00K derived: sum of 4 quarters · filed 2025-05-05 | ||
| 2023-12-31 | $497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.69M derived: sum of 2 quarters · filed 2025-03-11 | $1.60M derived: sum of 3 quarters · filed 2025-03-11 | $2.50M 10-K · filed 2025-03-11 | ||
| 2023-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.11M derived: sum of 2 quarters · filed 2024-11-12 | $2.00M 10-Q · filed 2024-11-12 | $719.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $812.00K 10-Q · filed 2024-08-05 | -$469.00K derived: sum of 3 quarters · filed 2024-08-05 | $161.00K derived: sum of 4 quarters · filed 2024-08-05 | ||
| 2023-03-31 | $893.00K 10-Q · filed 2024-05-13 | -$388.00K derived: sum of 2 quarters · filed 2024-05-13 | $242.00K derived: sum of 3 quarters · filed 2024-05-13 | -$598.00K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$651.00K derived: sum of 2 quarters · filed 2024-03-18 | -$1.49M derived: sum of 3 quarters · filed 2024-03-18 | -$1.40M 10-K · filed 2024-03-18 | ||
| 2022-09-30 | $630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$210.00K derived: sum of 2 quarters · filed 2023-11-13 | -$121.00K 10-Q · filed 2023-11-13 | $325.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$840.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$751.00K 10-Q · filed 2023-08-07 | -$1.23M 10-Q · filed 2022-08-04 | -$305.00K derived: sum of 3 quarters · filed 2023-08-07 | $396.00K derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $89.00K 10-Q · filed 2023-05-15 | $535.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.24M derived: sum of 3 quarters · filed 2023-05-15 | $1.39M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $1.15M derived: sum of 2 quarters · filed 2023-03-20 | $1.30M derived: sum of 3 quarters · filed 2023-03-20 | $984.00K 10-K · filed 2023-03-20 | ||
| 2021-09-30 | $701.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $855.00K derived: sum of 2 quarters · filed 2022-11-21 | $538.00K 10-Q · filed 2022-11-21 | $662.00K derived: sum of 4 quarters · filed 2022-11-21 | ||
| 2021-06-30 | $154.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-21 | -$163.00K 10-Q/A · filed 2022-11-21 | -$39.00K derived: sum of 3 quarters · filed 2022-11-21 | $1.53M derived: sum of 4 quarters · filed 2022-11-21 | ||
| 2021-03-31 | -$317.00K 10-Q · filed 2022-05-11 | -$193.00K derived: sum of 2 quarters · filed 2022-05-11 | $1.38M derived: sum of 3 quarters · filed 2022-05-11 | $932.00K derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.70M derived: sum of 2 quarters · filed 2022-03-22 | $1.25M derived: sum of 3 quarters · filed 2022-03-22 | $1.60M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.13M derived: sum of 2 quarters · filed 2021-11-10 | $1.47M 10-Q · filed 2021-11-10 | $1.06M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | -$447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$100.00K 10-Q · filed 2021-08-09 | -$507.00K derived: sum of 3 quarters · filed 2021-08-09 | -$632.00K derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $347.00K 10-Q · filed 2021-05-11 | -$60.00K derived: sum of 2 quarters · filed 2021-05-11 | -$185.00K derived: sum of 3 quarters · filed 2021-05-11 | $875.00K derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$532.00K derived: sum of 2 quarters · filed 2021-03-16 | $528.00K derived: sum of 3 quarters · filed 2021-03-16 | $688.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $935.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.09M 10-Q · filed 2020-11-10 | $1.38M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $1.22M 10-Q · filed 2020-07-28 | $1.51M derived: sum of 3 quarters · filed 2020-07-28 | |||
| 2019-03-31 | $160.00K 10-Q · filed 2020-05-11 | $449.00K derived: sum of 2 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $284.00K 10-K · filed 2020-03-25 | ||||
| 2018-09-30 | -$5.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |